SAB Biotherapeutics, Inc. (SABS)
3.71
-0.08
(-2.11%)
USD |
NASDAQ |
Aug 31, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics Net Income (Quarterly) : -22.49M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.49M |
| March 31, 2026 | -18.87M |
| December 31, 2025 | -2.845M |
| September 30, 2025 | 5.338M |
| June 30, 2025 | -10.11M |
| March 31, 2025 | -5.197M |
| December 31, 2024 | -11.39M |
| September 30, 2024 | -10.35M |
| June 30, 2024 | -7.336M |
| March 31, 2024 | -5.026M |
| December 31, 2023 | -22.86M |
| September 30, 2023 | -5.102M |
| Date | Value |
|---|---|
| June 30, 2023 | -6.881M |
| March 31, 2023 | -7.354M |
| December 31, 2022 | -7.875M |
| September 30, 2022 | -7.076M |
| June 30, 2022 | -4.776M |
| March 31, 2022 | 0.9859M |
| December 31, 2021 | -17.58M |
| September 30, 2021 | -4.061M |
| June 30, 2021 | -2.942M |
| March 31, 2021 | 1.410M |
| December 31, 2020 | -0.009M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.536M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 22.49M |
| EPS Diluted (Quarterly) | -0.282 |
| Enterprise Value | 212.26M |
| Earnings Yield | -44.75% |
| Normalized Earnings Yield | -58.72 |